Your search returned 1590 results.

Results
	321.	Randomised Phase 2 study of lapatinib and vinorelbine vs vinorelbine in patients with HER2 + metastatic breast cancer after lapatinib and trastuzumab treatment (KCSG BR11-16). [electronic resource] by Sim, Sung Hoon Park, In Hae Jung, Kyung Hae Kim, Sung-Bae Ahn, Jin-Hee Lee, Kyung-Hun Im, Seock-Ah Im, Young-Hyuck Park, Yeon Hee Sohn, Joohyuk Kim, Yu Jung Lee, Suee Kim, Hee-Jun Chae, Yee Soo Park, Kyong Hwa Nam, Byung-Ho Lee, Keun Seok Ro, Jungsil Producer: 20200619 In: British journal of cancer vol. 121 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	322.	Antitumor activity of HER-2 inhibitors. [electronic resource] by Rabindran, Sridhar K Producer: 20050908 In: Cancer letters vol. 227 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	323.	[A case of effective lapatinib/capecitabine therapy for HER2-positive breast cancer with multiple brain metastases]. [electronic resource] by Fujita, Yoshifumi Mizuta, Naruhiko Sakaguchi, Koichi Nakatsukasa, Katsuhiko Imai, Aya Umeda, Yoshimi Hamaoka, Asako Morita, Midori Shouji, Mari Goto, Mariko Taguchi, Tetsuya Producer: 20130107 In: Gan to kagaku ryoho. Cancer & chemotherapy vol. 39 Availability: No items available. Save to lists Add to cart (remove)
	324.	Objective response with lapatinib in patients with meningitis carcinomatosa derived from HER2/HER1-negative breast cancer. [electronic resource] by Onishi, Hideya Morisaki, Takashi Nakafusa, Yuji Nakashima, Yutaka Yokohata, Kazunori Katano, Mitsuo Producer: 20120515 In: International journal of clinical oncology vol. 16 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	325.	Phase I dose-escalation study of 5-day intermittent oral lapatinib therapy in patients with human epidermal growth factor receptor 2-overexpressing breast cancer. [electronic resource] by Chien, A Jo Munster, Pamela N Melisko, Michelle E Rugo, Hope S Park, John W Goga, Andrei Auerback, Glenna Khanafshar, Elham Ordovas, Karen Koch, Kevin M Moasser, Mark M Producer: 20140620 In: Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 32 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	326.	Health related quality of life of women in TEACH, a randomised placebo controlled adjuvant trial of lapatinib in early stage Human Epidermal Growth Factor Receptor (HER2) overexpressing breast cancer. [electronic resource] by Boyle, Frances M Smith, Ian E O'Shaughnessy, Joyce Ejlertsen, Bent Buzdar, Aman U Fumoleau, Pierre Gradishar, William Martin, Miguel Moy, Beverly Piccart-Gebhart, Martine Pritchard, Kathleen I Lindquist, Deborah Amonkar, Mayur Huang, Yingjie Rappold, Erica Williams, Lisa S Wang-Silvanto, Jing Kaneko, Tomomi Finkelstein, Dianne M Goss, Paul E Producer: 20150728 In: European journal of cancer (Oxford, England : 1990) vol. 51 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	327.	Mechanisms of lapatinib resistance in HER2-driven breast cancer. [electronic resource] by D'Amato, Valentina Raimondo, Lucia Formisano, Luigi Giuliano, Mario De Placido, Sabino Rosa, Roberta Bianco, Roberto Producer: 20160307 In: Cancer treatment reviews vol. 41 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	328.	Preparation of Antibodies and Development of an Enzyme-Linked Immunosorbent Assay for the Tyrosine Kinase Inhibitors Lapatinib and Nilotinib. [electronic resource] by Saita, Tetsuya Yamamoto, Yuta Shin, Masashi Nakano, Yukitaka Producer: 20160725 In: Biological & pharmaceutical bulletin vol. 38 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	329.	Inhibition of human UDP-glucuronosyltransferase enzymes by lapatinib, pazopanib, regorafenib and sorafenib: Implications for hyperbilirubinemia. [electronic resource] by Miners, John O Chau, Nuy Rowland, Andrew Burns, Kushari McKinnon, Ross A Mackenzie, Peter I Tucker, Geoffrey T Knights, Kathleen M Kichenadasse, Ganessan Producer: 20170505 In: Biochemical pharmacology vol. 129 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	330.	The HER2 inhibitor lapatinib potentiates doxorubicin-induced cardiotoxicity through iNOS signaling. [electronic resource] by Hsu, Wan-Tseng Huang, Ching-Ying Yen, Christopher Y T Cheng, Ann-Lii Hsieh, Patrick C H Producer: 20190827 In: Theranostics vol. 8 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	331.	Mitochondria Targeting and Destabilizing Hyaluronic Acid Derivative-Based Nanoparticles for the Delivery of Lapatinib to Triple-Negative Breast Cancer. [electronic resource] by Lee, Song Yi Cho, Hyun-Jong Producer: 20200227 In: Biomacromolecules vol. 20 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	332.	EGFR and HER-2 antagonists in breast cancer. [electronic resource] by O'Donovan, Norma Crown, John Producer: 20070727 In: Anticancer research vol. 27 Availability: No items available. Save to lists Add to cart (remove)
	333.	The use of breast imaging for predicting response to neoadjuvant lapatinib, trastuzumab and their combination in HER2-positive breast cancer: Results from Neo-ALTTO. [electronic resource] by Di Cosimo, S Campbell, C Azim, H A Galli, G Bregni, G Curigliano, G Criscitiello, C Izquierdo, M de la Pena, L Fumagalli, D Fein, L Vinholes, J Ng, W M J Colleoni, M Ferro, A Naume, B J Patel, A Huober, J Piccart-Gebhart, M J Baselga, J de Azambuja, E Producer: 20180828 In: European journal of cancer (Oxford, England : 1990) vol. 89 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	334.	Efficacy and safety of trastuzumab, lapatinib, and paclitaxel neoadjuvant treatment with or without prolonged exposure to anti-HER2 therapy, and with or without hormone therapy for HER2-positive primary breast cancer: a randomised, five-arm, multicentre, open-label phase II trial. [electronic resource] by Masuda, N Toi, M Yamamoto, N Iwata, H Kuroi, K Bando, H Ohtani, S Takano, T Inoue, K Yanagita, Y Kasai, H Morita, S Sakurai, T Ohno, S Producer: 20181008 In: Breast cancer (Tokyo, Japan) vol. 25 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	335.	Computational Drug Target Screening through Protein Interaction Profiles. [electronic resource] by Vilar, Santiago Quezada, Elías Uriarte, Eugenio Costanzi, Stefano Borges, Fernanda Viña, Dolores Hripcsak, George Producer: 20180530 In: Scientific reports vol. 6 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	336.	Human epidermal growth factor receptor 2/neu as a novel therapeutic target in sinonasal undifferentiated carcinoma. [electronic resource] by Takahashi, Yoko Lee, Junegoo Pickering, Curtis Bell, Diana Jiffar, Tilahun W Myers, Jeffrey N Hanna, Ehab Y Kupferman, Michael E Producer: 20180226 In: Head & neck vol. 38 Suppl 1 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	337.	Porous Matrix Stiffness Modulates Response to Targeted Therapy in Breast Carcinoma. [electronic resource] by Liu, Cuiying Li, Xiang Hua, Wenda Li, Jianjun Han, Xinxiao Ha, Qing Feng, Jiantao Liao, Fulong Li, Dongguo Han, Dong Producer: 20180205 In: Small (Weinheim an der Bergstrasse, Germany) vol. 12 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	338.	Dual-targeting strategy using trastuzumab and lapatinib in a patient with HER2 gene amplification in recurrent metachronous metastatic gallbladder carcinoma. [electronic resource] by Ye, Minfeng Lv, Jieqing Xu, Guangen Wang, Wei Jing, Yuanming Sun, Aijing Lu, Zengxin Wu, Xue Liu, Yichuan Shao, Yang W Liu, Fang Tao, Feng Producer: 20191218 In: The Journal of international medical research vol. 47 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	339.	Autophagy can contribute to cell death when combining targeted therapy. [electronic resource] by Amaravadi, Ravi Producer: 20100625 In: Cancer biology & therapy vol. 8 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	340.	Lapatinib monotherapy in patients with relapsed, advanced, or metastatic breast cancer: efficacy, safety, and biomarker results from Japanese patients phase II studies. [electronic resource] by Toi, M Iwata, H Fujiwara, Y Ito, Y Nakamura, S Tokuda, Y Taguchi, T Rai, Y Aogi, K Arai, T Watanabe, J Wakamatsu, T Katsura, K Ellis, C E Gagnon, R C Allen, K E Sasaki, Y Takashima, S Producer: 20091224 In: British journal of cancer vol. 101 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

First
Previous
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
Next
Last

Refine your search

Availability

Authors

Topics

Languages

Your search returned 1590 results.